ARCHIVES

FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says.

This article is from The Cancer Letter archive.

Vol. 31 No. 13 | April 1, 2005

Download PDF Visit The Full Archive

Related Articles

NIH Panel finalizes Consensus Statement; Two Panelists Join In Minority Opinion

March 28, 1997

In Brief: Hutchinson Awarded $8 Million Grant For Pancreatic, Colorectal Cancer Studies

September 18, 1998

NCI To Fund Study of Stomach Cancer In Poles, Polish Americans, In Warsaw And Chicago Areas

April 17, 1992

TV Networks Donate A Prime-Time Hour To Raise Funds For Cancer Research; AACR To Administer Funds, Select Research “Dream Teams.”

May 30, 2008

Smokers’ Quitlines Work, California Study Finds

October 25, 2002

Managed Care Plans Seek Cost Efficacy, Not Research, Center Directors Warned

March 17, 1995